COMMENTARY: Review: ACE inhibitors delay onset of microalbuminuria in diabetes without nephropathy and reduce mortality in diabetic nephropathy

McFarlane, Philip A.
September 2006
ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p35
Academic Journal
The article presents comments on the study by G.F. Strippoli and colleagues on the role of Angiotensin-Converting Enzyme inhibitors in diabetic nephropathy. According to the author, meta-analysis is a strong method for computing the results of clinical trials and the face validity test is more powerful than the statistical test in resolving similar trials.


Related Articles

  • Review: ACE inhibitors delay onset of microalbuminuria in diabetes without nephropathy and reduce mortality in diabetic nephropathy.  // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p35 

    The article presents a study conducted by G.F. Strippoli, M.C. Craig, F.P. Schena and J.C. Craig on the role of Angiotensin-Converting Enzyme (ACE) inhibitors in diabetic nephropathy. The random-effects model using meta-analysis revealed that ACE inhibitors were more efficient in preventing the...

  • Diabetic Kidney Disease: Preventing Dialysis and Transplantation. Loon, Nicholas Robert // Clinical Diabetes;Spring2003, Vol. 21 Issue 2, p55 

    Diabetic nephropathy is characterized by proteinuria and progressive kidney failure. The course of diabetic nephropathy is similar in type 1 and type 2 diabetes, although the diagnosis of type 2 diabetes is frequently delayed because of its insidious nature, giving the appearance of an earlier...

  • Delaying diabetic nephropathy in normotensive patients.  // Patient Care;12/15/1997, Vol. 31 Issue 20, p146 

    Focuses on the role of angiotensin-converting enzyme (ACE) inhibitors in preventing diabetic nephropathy in patients with diabetes, while monitoring the albumin excretion rates. Indepth information on diabetes; Reference to some of the medical changes which occur in persons with diabetes.

  • II/ACE Genotype Highly Influenced by ACE Inhibition.  // Kidney;Sep/Oct98, Vol. 7 Issue 5, p206 

    Discusses the abstract of a study entitled 'Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy,' by P. Jacobsen, K. Rossing, P. Rossing and others, published in the 1998 issue of 'Kidney International.'

  • Efficacy of Pentoxifylline in the Management of Microalbuminuria in Patients with Diabetes. Rodríguez-Morán, Martha; Guerrero-Romero, Fernando // Current Diabetes Reviews;2008, Vol. 4 Issue 1, p55 

    The prevalence of diabetes and its complications is increasing worldwide. Among the microvascular complications, diabetic nephropathy is the most frequent cause of end-stage renal disease. Although angiotensin-converting-enzyme inhibitors have been cited as the first line of therapy for the...

  • ACE Inhibitor-Angiotensin Receptor Blocker Combinations: A Clinician's Perspective. Doulton, T. W. R. // Mini Reviews in Medicinal Chemistry;May2006, Vol. 6 Issue 5, p491 

    ACE Inhibitors (ACEI) and angiotensin receptor blockers (ARB) inhibit the renin-angiotensin system, but ACEI may do so incompletely when administered as monotherapy at conventional doses. In theory, combining an ACEI and ARB might be beneficial, whereas clinical evidence for this approach in...

  • Diabetic Nephropathy--The Family Physician's Role. Roett, Michelle A.; Liegl, Sarah; Jabbarpour, Yalda // American Family Physician;5/1/2012, Vol. 85 Issue 9, p883 

    Nearly one-half of persons with chronic kidney disease have diabetes mellitus. Diabetes accounted for 44 percent of new cases of kidney failure in 2008. Diabetic nephropathy, also called diabetic kidney disease, is associated with significant macrovascular risk, and is the leading cause of...

  • Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy. Naresh, V. V. S.; Reddy, A. L. K.; Sivaramakrishna, G.; Sharma, P. V. G. K.; Vardhan, R. V.; Kumar, V. Siva // Indian Journal of Nephrology;Oct-Dec2009, Vol. 19 Issue 4, p145 

    Nephropathy is an important and a frequent complication of long-term type II diabetic nephropathy. Strong evidence exists that genetic predisposition plays a major role in the development of diabetic nephropathy. Recent studies have implicated association between angiotensin converting enzyme...

  • Insertion/deletion polymorphism in ACE gene as a predictor for progression of diabetic nephropathy. Sung-Kyu Ha; Jung-Kun Seo // Kidney International Supplement;Sep1997, Issue 60, pS-28 

    Investigates the insertion/deletion polymorphism in the angiotensin I-converting enzyme (ACE) as a predictor of progression in diabetic nephropathy. Examination of specific candidate genes predisposing to diabetic nephropathy in a case control design; Determination of whether a particular...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics